A war is being raged against the Aedes aegypti mosguito which is responsible for the transmission of theĀ ZIKA fever, Dengue and Chikungunya in humans. The strategy against the mosquito involves manipulating the genetic profile of the insects so as to limiting the life-soan of its progeny.
A British company, called OXITEC, is a biotech company tasked with pioneering in environmentally friendly ways to control insect pests that spread disease and damage crops. The company has developed a strain of the mosquito referred to as OX513A.
The normal mosquito
After taking a blood meal, female Aedes aegypti mosquitoes produce on average 100 to 200 eggs per batch. The females can produce up to five batches of eggs during a lifetime. The female Aedes aegypti lays her eggs separately unlike most species. Not all eggs are laid at once, but they can be spread out over hours or days, depending on the availability of suitable substrates. Eggs will most often be placed at varying distances above the water line. The female mosquito will not lay the entire clutch at a single site, but rather spread out the eggs over several sites.
The insects goes through a complete metamorphosis (change) with an egg, larvae, pupae, and adult stage. The adult life span can range from two weeks to a month depending on environmental conditions. The life cycle of Aedes aegypti can be completed within one-and-a-half to three weeks.
The engineered mosquito
Oxitec uses advanced genetics to insert a self-limiting gene into its mosquitoes. The gene is passed on to the modified insect's offspring, so when Oxitec mosquitoes are released into the wild and mate with wild females their offspring inherit the self-limiting trait. The resulting offspring will die before reaching adulthood and the local mosquito population will decline.
The engineered male mosquito competes with normal males for normal females whose progeny will die before reaching adulthood. The progeny also compete with normal progeny for breeding spaces and resources before they die.
OX513A has regulatory approvals for import and contained testing in Brazil, Cayman Islands, France, India, Malaysia, Singapore, Thailand, USA and Vietnam. Open field trials have taken place in both Grand Cayman and Malaysia, and are currently also under-way in Brazil. In 2015 Brazil reported 3,530 cases of babies born with the condition called Microcephaly results in an infant with a head circumference below the average size, and other facial characteristics.
Add Comment
This policy contains information about your privacy. By posting, you are declaring that you understand this policy:
- Your name, rating, website address, town, country, state and comment will be publicly displayed if entered.
- Aside from the data entered into these form fields, other stored data about your comment will include:
- Your IP address (not displayed)
- The time/date of your submission (displayed)
- Your email address will not be shared. It is collected for only two reasons:
- Administrative purposes, should a need to contact you arise.
- To inform you of new comments, should you subscribe to receive notifications.
- A cookie may be set on your computer. This is used to remember your inputs. It will expire by itself.
This policy is subject to change at any time and without notice.
These terms and conditions contain rules about posting comments. By submitting a comment, you are declaring that you agree with these rules:
- Although the administrator will attempt to moderate comments, it is impossible for every comment to have been moderated at any given time.
- You acknowledge that all comments express the views and opinions of the original author and not those of the administrator.
- You agree not to post any material which is knowingly false, obscene, hateful, threatening, harassing or invasive of a person's privacy.
- The administrator has the right to edit, move or remove any comment for any reason and without notice.
Failure to comply with these rules may result in being banned from submitting further comments.
These terms and conditions are subject to change at any time and without notice.
Comments